Page last updated: 2024-10-30

lansoprazole and Hemorrhagic Shock

lansoprazole has been researched along with Hemorrhagic Shock in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Research Excerpts

ExcerptRelevanceReference
"The protective effects of the proton pump inhibitor lansoprazole on gastric mucosal damage induced by ethanol-HCl or hemorrhagic shock were investigated in the present study."3.70Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. ( Blandizzi, C; Carignani, D; Colucci, R; Del Tacca, M; Gherardi, G; Lazzeri, G; Marveggio, C; Natale, G, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blandizzi, C1
Natale, G1
Gherardi, G1
Lazzeri, G1
Marveggio, C1
Colucci, R1
Carignani, D1
Del Tacca, M1

Other Studies

1 other study available for lansoprazole and Hemorrhagic Shock

ArticleYear
Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Ethanol; Gastric Acid; Gastric

1999